Immunotherapy combined with chemotherapy in the treatment for rare primary mucoepidermoid carcinoma of the liver: a case report

Primary mucoepidermoid carcinoma of the liver (PMCL) is rare in the hepatic system, with no standard treatment and poor prognosis with a median overall survival of only 120 days. PMCL with immunotherapy has not been reported yet. Here, we present a case of PMCL treated by immunotherapy and chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Linghui, Deng, Jianzhong, Wang, Yue, Liu, Qian, Li, Wenjing, Zhu, Qi, Gu, Xiaoyan, Lu, Wenbin, Zhang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997629/
https://www.ncbi.nlm.nih.gov/pubmed/36729901
http://dx.doi.org/10.1097/CAD.0000000000001476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997629/
https://www.ncbi.nlm.nih.gov/pubmed/36729901
http://dx.doi.org/10.1097/CAD.0000000000001476

Ejemplares similares